Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitelillyventures.com
Phone3176513050
Emaillilly_ventures@li...
Employees4
DescriptionPharmaceutical Investor

Funds

First Fund, 8/2009 $200M

Offices

HQ
115 W. Washington Street
Suite 1680 - South
Indianapolis, IN, 46204
USA

People

Venture Partner
Venture Partner
Managing Director
Senior Associate
Office Manager

Tags

Lilly Ventures

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Our primary goal is to facilitate the success of companies in our areas of focus through early to expansion stage investments and value-adding resources.

Lilly Ventures currently has $200 million under management and focuses on three major areas of interest.

Recent Milestones

Investments

Company Date Round Size Participants
Æglea BioTherapeutics 2/2014Series A$12M3
Aileron Therapeutics 11/2013Series E$30M6
Protagonist Therapeutics 6/2013Series B$14M3
Aileron Therapeutics 1/2013Series D$12M6
Sutro Biopharma 5/2012Series C$16.5M5
Receptos 3/2012Venture Round$30M6
HemaQuest Pharmaceuticals 3/2012Series B$13M5
Cerulean Pharma 12/2011Series D$15M5
Nimbus Discovery 6/2011Series A$24M3
Sutro Biopharma 11/2010Series C$36.5M5
Cerulean Pharma 11/2010Series C$24M5
Cylene Pharmaceuticals 9/2010Series D$12M6
HemaQuest Pharmaceuticals 4/2010Series B$12M4
FORMA Therapeutics 12/2009Series B$3M3
FORMA Therapeutics 12/2009Series B$25.5M3
Receptos 11/2009Series A$25M4
Trinity Biosystems 11/2009Debt$7.5M5
Viamet Pharmaceuticals 7/2009Series B$25M6
Aileron Therapeutics 6/2009Series D$40M6
Avid Radiopharmaceuticals 5/2009Series D$34.5M8
Intradigm Corporation 1/2009Series B$21.4M8
Avid Radiopharmaceuticals 5/2007Series C$26M6
Cylene Pharmaceuticals 1/2007Series C$44M2
Fluidigm 1/2007Series E$17M10
Protagonist Therapeutics 9/2006Series A$9M3
MedManage Systems 4/2006Series D$10.8M4
InnoCentive 2/2006Series A$9M3
Avid Radiopharmaceuticals 1/2006Series A$8.9M4

Videos

Sources

  1. With $200M, Lilly spins out venture biz (fiercebiotech.com) [edit]
  2. Æglea BioTherapeutics closes $12 million Series A financing (otc.utexas.edu) [edit]
  3. Aileron Therapeutics Secures $30M in Series E Equity Financing (finsmes.com) [edit]
  4. Protagonist Therapeutics Raises $14 Million in Series B Venture Financing (protagonist-inc.com) [edit]
  5. Aileron Therapeutics Raises $12M in Series D Financing (finsmes.com) [edit]
  6. Sutro Closes $16.5 Million Second Tranche of Series C Financing (finance.yahoo.com) [edit]
  7. Osage University Partners Source [edit]
  8. HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing (hemaquest.com) [edit]
  9. Cerulean Pharma Closes $15m Series D Financing (finsmes.com) [edit]
  10. Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery (xconomy.com) [edit]
  11. Sutro Biopharma Secures $36.5M in Series C Financing (finsmes.com) [edit]
  12. Cerulean Pharma Closes $24M Series C Financing (finsmes.com) [edit]
  13. Cylene Pharmaceuticals Gets $12M (socaltech.com) [edit]
  14. HemaQuest books $12M Series B to advance mid-stage programs (fiercebiotech.com) [edit]
  15. Forma Therapeutics lands $3M in equity (masshightech.com) [edit]
  16. AltAssets (altassets.com) [edit]
  17. Receptos raises $25M in Series A (fiercebiotech.com) [edit]
  18. SEC D/A (sec.gov) [edit]
  19. SEC (sec.gov) [edit]
  20. Aileron Therapeutics Closes Series D Financing (zibb.com) [edit]
  21. Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing (avidrp.com) [edit]
  22. Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive (fiercebiotech.com) [edit]
  23. Avid RP Closes $26 Million Series C Financing (avidrp.com) [edit]
  24. Cylene Pharmaceuticals Closes $44 Million Series C Financing (rctech.com) [edit]
  25. Life science fluid control company, Fluidigm, raises $17M more (venturebeat.com) [edit]
  26. PROTAGONIST SECURES US$9 MILLION FINANCING FOR NOVEL THERAPEUTIC PROGRAMS (protagonist-inc.com) [edit]
  27. MedManage Systems, Inc. Closes $10.75 Million Series D (biospacejobs.com) [edit]
  28. InnoCentive Secures $9 Million in Venture Capital Funding Led by Spencer Trask Ventures, Inc. (innocentive.com) [edit]
  29. Avid RP Closes $8.9 Million Financing to Support Development of Alzheimer's Diagnostic and Prognostic Agents (avidrp.com) [edit]
Edit This Page
Last Edited 3/18/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy